Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

New requirements placed on European notified bodies aim to raise standards

This article was originally published in Clinica

Executive Summary

Notified bodies in the European Union will face extensive new documentation requirements if they are to ward off their critics who argue that standards are lax and uneven. Recommendations in a new working document from the European Commission for the designation and monitoring of the third-party certification bodies, which assess products for their compliance with the EU medical device directives, are far more comprehensive than the requirements laid out in the directives themselves.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT081718

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel